PharmaShots | Incisive News in 3 Shots

Subscribe Now

Dermavant

Philip Brown & Anna Tallman of Dermavant Shares Insights on the Approval of its Topical Treatment for Plaque Psoriasis

Philip Brown & Anna Tallman of Dermavant Shares Insights on the Approval of its Topical Treatment for Plaque Psoriasis

August 1, 2022

Dermavant’s Vtama (tapinarof) Receives the US FDA’s Approval for the Treatment of Plaque Psoriasis in Adults

Dermavant’s Vtama (tapinarof) Receives the US FDA’s Approval for the Treatment of Plaque Psoriasis in Adults

May 24, 2022

Dermavant Presents Results of Tapinarof Cream in P-III (PSOARING 3) Trial for the Treatment of Plaque Psoriasis at AAD 2022

Dermavant Presents Results of Tapinarof Cream in P-III (PSOARING 3) Trial for the Treatment of Plaque Psoriasis at AAD 2022

March 28, 2022

PharmaShots Interview: Dermavant’s Philip Brown Shares Insight on the P-III (PSOARING 3) Study of Tapinarof

PharmaShots Interview: Dermavant’s Philip Brown Shares Insight on the P-III (PSOARING 3) Study of Tapinarof

March 15, 2022

Dermavant Reports Results of Tapinarof in P-III (PSOARING 3) Study for the Treatment of Plaque Psoriasis

Dermavant Reports Results of Tapinarof in P-III (PSOARING 3) Study for the Treatment of Plaque Psoriasis

January 17, 2022

PharmaShots Weekly Snapshots (August 09, 13, 2021)

PharmaShots Weekly Snapshots (August 09, 13, 2021)

August 13, 2021

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us